Celestina Mazzotta, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Scleroderma, Systemic | 6 | 2017 | 344 | 1.190 |
Why?
|
Microvessels | 3 | 2020 | 577 | 0.740 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 2 | 2020 | 104 | 0.730 |
Why?
|
Cathepsin B | 1 | 2020 | 80 | 0.720 |
Why?
|
Endothelial Cells | 6 | 2024 | 3548 | 0.690 |
Why?
|
Dermis | 1 | 2020 | 202 | 0.650 |
Why?
|
Down-Regulation | 2 | 2024 | 2919 | 0.570 |
Why?
|
Glucuronidase | 1 | 2017 | 202 | 0.500 |
Why?
|
Semaphorins | 1 | 2015 | 96 | 0.490 |
Why?
|
Lysosomes | 1 | 2020 | 924 | 0.490 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2015 | 263 | 0.450 |
Why?
|
Myocardial Ischemia | 1 | 2021 | 2113 | 0.350 |
Why?
|
Blood Vessels | 1 | 2015 | 1113 | 0.340 |
Why?
|
Adipose Tissue | 1 | 2021 | 3312 | 0.320 |
Why?
|
Neovascularization, Pathologic | 2 | 2015 | 2645 | 0.300 |
Why?
|
Neuropilin-1 | 2 | 2017 | 90 | 0.260 |
Why?
|
Shiga Toxin | 1 | 2024 | 36 | 0.230 |
Why?
|
Peripheral Vascular Diseases | 2 | 2015 | 488 | 0.200 |
Why?
|
von Willebrand Factor | 1 | 2024 | 673 | 0.170 |
Why?
|
Neovascularization, Physiologic | 2 | 2017 | 1349 | 0.170 |
Why?
|
Blotting, Western | 2 | 2017 | 5035 | 0.160 |
Why?
|
Chemokine CCL2 | 1 | 2021 | 605 | 0.150 |
Why?
|
Skin | 4 | 2017 | 4484 | 0.130 |
Why?
|
Angiostatic Proteins | 1 | 2014 | 2 | 0.120 |
Why?
|
Interleukin-1beta | 1 | 2021 | 999 | 0.120 |
Why?
|
Raynaud Disease | 1 | 2015 | 79 | 0.120 |
Why?
|
Cells, Cultured | 3 | 2020 | 18965 | 0.110 |
Why?
|
Aorta | 1 | 2021 | 2042 | 0.110 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2015 | 353 | 0.100 |
Why?
|
Signal Transduction | 1 | 2015 | 23445 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1886 | 0.100 |
Why?
|
Up-Regulation | 1 | 2021 | 4124 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 3810 | 0.090 |
Why?
|
Bariatric Surgery | 1 | 2021 | 992 | 0.090 |
Why?
|
Interleukin-6 | 1 | 2021 | 3208 | 0.090 |
Why?
|
Chemokines | 1 | 2014 | 960 | 0.090 |
Why?
|
Obesity | 2 | 2021 | 12947 | 0.080 |
Why?
|
Cell Adhesion Molecules | 1 | 2014 | 1600 | 0.080 |
Why?
|
Aged | 8 | 2021 | 169289 | 0.080 |
Why?
|
Microscopy, Fluorescence | 1 | 2015 | 2645 | 0.080 |
Why?
|
Middle Aged | 9 | 2021 | 220895 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2017 | 3492 | 0.070 |
Why?
|
Lung Diseases, Interstitial | 1 | 2015 | 918 | 0.070 |
Why?
|
Microscopic Angioscopy | 2 | 2015 | 20 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2872 | 0.060 |
Why?
|
Atherosclerosis | 1 | 2021 | 3408 | 0.060 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9420 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2015 | 3702 | 0.060 |
Why?
|
Phosphorylation | 1 | 2015 | 8320 | 0.060 |
Why?
|
Male | 9 | 2021 | 360804 | 0.060 |
Why?
|
Adult | 8 | 2021 | 221177 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2017 | 11076 | 0.050 |
Why?
|
Receptors, Estrogen | 1 | 2011 | 2208 | 0.050 |
Why?
|
Female | 9 | 2021 | 392644 | 0.050 |
Why?
|
Humans | 11 | 2024 | 761504 | 0.050 |
Why?
|
Inflammation | 1 | 2021 | 10773 | 0.050 |
Why?
|
Semaphorin-3A | 1 | 2015 | 39 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15500 | 0.030 |
Why?
|
Cathelicidins | 1 | 2015 | 80 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2021 | 64680 | 0.030 |
Why?
|
Skin Ulcer | 1 | 2014 | 130 | 0.030 |
Why?
|
Melanoma | 1 | 2011 | 5709 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2017 | 1186 | 0.020 |
Why?
|
Skin Neoplasms | 1 | 2011 | 5821 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9326 | 0.020 |
Why?
|
Fibrosis | 1 | 2015 | 2049 | 0.020 |
Why?
|
Autoimmunity | 1 | 2014 | 1356 | 0.020 |
Why?
|
Wound Healing | 1 | 2017 | 2805 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2017 | 58976 | 0.020 |
Why?
|
Cell Movement | 1 | 2017 | 5203 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14605 | 0.020 |
Why?
|
Biopsy | 1 | 2015 | 6766 | 0.010 |
Why?
|
Body Mass Index | 1 | 2021 | 12953 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2011 | 3595 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2017 | 10445 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4243 | 0.010 |
Why?
|
Alleles | 1 | 2011 | 6863 | 0.010 |
Why?
|
Logistic Models | 1 | 2015 | 13255 | 0.010 |
Why?
|
Apoptosis | 1 | 2015 | 9486 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 22176 | 0.010 |
Why?
|
Lung | 1 | 2015 | 10000 | 0.010 |
Why?
|
Prospective Studies | 1 | 2011 | 54425 | 0.000 |
Why?
|